Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 94 of 94 entries
View as:

The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis

Phase: N/A Priority: Normal
NCT ID: NCT02855632 Org: User:
Start: 08/31/16 End: 12/31/19 Due: 12/31/20

Integration of the 5G-based Remote Healthcare System in Critical Care

Phase: N/A Priority: Normal
NCT ID: NCT06485518 Org: User:
Start: 07/01/22 End: 08/01/23 Due: 08/01/24

Gram-negative Bacilli and MRSA Screening in ICU in China

Phase: N/A Priority: Normal
NCT ID: NCT04310722 Org: User:
Start: 08/06/19 End: 12/31/20 Due: 12/31/21

Early Endovascular Treatment in Isolated Internal Carotid Artery Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT07016854 Org: User:
Start: 06/30/25 End: 12/31/27 Due: 12/31/28

Epidemiology of Klebsiella Pneumoniae in China

Phase: N/A Priority: Normal
NCT ID: NCT03598543 Org: User:
Start: 06/01/18 End: 12/31/18 Due: 12/31/19

Clinical Application of Carbon Nanoparticles in Lymph Node Tracing and Surgery Guiding of Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06783985 Org: User:
Start: 03/16/22 End: 04/20/24 Due: 04/20/25

The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02418884 Org: User:
Start: 04/30/15 End: 03/31/18 Due: 03/31/19

Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC

Phase: N/A Priority: Normal
NCT ID: NCT06699459 Org: User:
Start: 11/14/24 End: 11/15/26 Due: 11/15/27

The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT06895369 Org: User:
Start: 05/01/25 End: 12/31/33 Due: 12/31/34

First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06491355 Org: User:
Start: 07/01/24 End: 06/30/26 Due: 06/30/27

Mobile Phone-based Smoking Cessation Program

Phase: N/A Priority: Normal
NCT ID: NCT06747182 Org: User:
Start: 10/01/22 End: 11/01/23 Due: 11/01/24

Movement Disorder Survey in East China

Phase: N/A Priority: Normal
NCT ID: NCT01168388 Org: User:
Start: 04/30/10 End: 08/31/10 Due: 08/31/11

Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT06633809 Org: User:
Start: 11/22/21 End: 03/01/27 Due: 03/01/28

Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05301660 Org: User:
Start: 03/22/22 End: 02/15/23 Due: 02/15/24

Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05972655 Org: User:
Start: 08/02/23 End: 05/01/26 Due: 05/01/27

Liquid Biopsy Based Multiomics Study for Colorectal Cancer Early Screening

Phase: N/A Priority: Normal
NCT ID: NCT06258434 Org: User:
Start: 02/10/24 End: 09/10/24 Due: 09/10/25

Application Study of Infusing Irritant Medications Through Midline Catheter Based on Real World Study

Phase: N/A Priority: Normal
NCT ID: NCT05710835 Org: User:
Start: 12/01/22 End: 06/30/24 Due: 06/30/25

Prospective Clinical Cohort Study of Depression

Phase: N/A Priority: Normal
NCT ID: NCT05775809 Org: User:
Start: 06/15/23 End: 05/20/24 Due: 05/20/25

'WeChat WeQuit' Smoking Cessation Program

Phase: N/A Priority: Normal
NCT ID: NCT03169686 Org: User:
Start: 03/19/20 End: 11/16/22 Due: 11/16/23